200 related articles for article (PubMed ID: 25319834)
1. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
[TBL] [Abstract][Full Text] [Related]
3. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698
[TBL] [Abstract][Full Text] [Related]
5. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
Mok Y; Lee JC; Lum JH; Petersson F
Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
[TBL] [Abstract][Full Text] [Related]
6. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
[TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors.
Liu X; Yin X; Li D; Li K; Zhang H; Lu J; Zhou L; Gao J; Wang J; Wu H; Liang Z
Mod Pathol; 2023 Oct; 36(10):100266. PubMed ID: 37391169
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
[TBL] [Abstract][Full Text] [Related]
9. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
[TBL] [Abstract][Full Text] [Related]
12. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.
Liu YJ; Wang W; Yeh J; Wu Y; Mantilla JG; Fletcher CDM; Ricciotti RW; Chen EY
Mod Pathol; 2021 Jul; 34(7):1373-1383. PubMed ID: 33727696
[TBL] [Abstract][Full Text] [Related]
13. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
[TBL] [Abstract][Full Text] [Related]
14. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
[TBL] [Abstract][Full Text] [Related]
15. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.
Carter JM; Caron BL; Dogan A; Folpe AL
Am J Surg Pathol; 2015 Jan; 39(1):75-83. PubMed ID: 25025444
[TBL] [Abstract][Full Text] [Related]
16. Mutational landscape and genetic signatures of cell-free DNA in tumour-induced osteomalacia.
Wu N; Zhang Z; Zhou X; Zhao H; Ming Y; Wu X; Zhang X; Yang XZ; Zhou M; Bao H; Chen W; Wu Y; Liu S; Wang H; Niu Y; Li Y; Zheng Y; Shao Y; Gao N; Yang Y; Liu Y; Li W; Liu J; Zhang N; Yang X; Xu Y; Li M; Sun Y; Su J; Zhang J; Xia W; Qiu G; Liu Y; Liu J; Wu Z
J Cell Mol Med; 2020 May; 24(9):4931-4943. PubMed ID: 32277576
[TBL] [Abstract][Full Text] [Related]
17. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
[TBL] [Abstract][Full Text] [Related]
18. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
[TBL] [Abstract][Full Text] [Related]
19. Case report: Novel NIPBL-BEND2 fusion gene identified in osteoblastoma-like phosphaturic mesenchymal tumor of the fibula.
Sakai T; Okuno Y; Murakami N; Shimoyama Y; Imagama S; Nishida Y
Front Oncol; 2022; 12():956472. PubMed ID: 36686800
[TBL] [Abstract][Full Text] [Related]
20. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
